Phase IB Study Using Sunitinib Plus Radiation Therapy for Cancer Patients
- Status
- COMPLETED
- Phase
- PHASE1
Clinical Trials Related to Head and Neck Cancer
Related studies linked through entity extraction aliases.
Can Cytokines Predict the Severity of Acute Mucositis and the Need for Gastrostomy Tubes (PEG)?
- Status
- UNKNOWN
- Phase
- N/A
MRX, Radiation, and Chemotherapy for Patients With Resected Squamous Cell Carcinoma of the Head and Neck
- Status
- TERMINATED
- Phase
- PHASE1
Bortezomib and Docetaxel in Treating Patients With Recurrent or Metastatic Head and Neck Cancer
- Status
- COMPLETED
- Phase
- PHASE2
Cisplatin, Bevacizumab, and Intensity-Modulated Radiation Therapy in Treating Patients With Stage III or Stage IV Head and Neck Cancer
- Status
- COMPLETED
- Phase
- PHASE2
Iodine I 131 in Treating Patients With Thyroid Cancer
- Status
- TERMINATED
- Phase
- NA
AP5346 or Oxaliplatin in Treating Patients With Metastatic and/or Unresectable Recurrent Head and Neck Cancer
- Status
- UNKNOWN
- Phase
- NA
High Dose vs Low Dose I 131 +/- rhTSH for Differentiated Thyroid Cancer
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- PHASE3
Side Effects of High-Dose Intensity-Modulated Radiation Therapy in Treating Patients With Advanced Head and Neck Cancer
- Status
- COMPLETED
- Phase
- N/A
Study of Proxinium Plus Best Supportive Care Versus Best Supportive Care for Patients With Advanced Head and Neck Cancer
- Status
- TERMINATED
- Phase
- PHASE2/PHASE3
A Study of Erlotinib (Tarceva) in Participants With Resected Head and Neck Squamous Cell Cancer
- Status
- TERMINATED
- Phase
- PHASE3
A Phase II Trial of Cetuximab and Bevacizumab in Patients With Recurrent or Metastatic Head and Neck Cancer
- Status
- COMPLETED
- Phase
- PHASE2
Amifostine With IMRT for Submandibular and Sublingual Salivary Sparing During Head and Neck Cancer Treatment
- Status
- TERMINATED
- Phase
- PHASE2
Phase I of Biologics and Chemoradiation Therapy for Advanced Head and Neck Cancer
- Status
- COMPLETED
- Phase
- PHASE1
Vaccine Therapy in Treating Patients With Head and Neck Cancer
- Status
- COMPLETED
- Phase
- PHASE1
Zalutumumab in Combination With Chemotherapy and Radiotherapy in Head and Neck Cancer
- Status
- TERMINATED
- Phase
- PHASE1/PHASE2
Secondary Primary Tumor Prevention With EGFR, OSI-774, and Cyclooxygenase-2
- Status
- COMPLETED
- Phase
- PHASE1
PET/CT to Image Hypoxia in Head and Neck Tumours
- Status
- COMPLETED
- Phase
- EARLY_PHASE1
Pemetrexed and Gemcitabine in Patients With Advanced Head and Neck Cancer
- Status
- TERMINATED
- Phase
- PHASE2
Treatment of Head & Neck Cancer With Chemotherapy and Radiation
- Status
- COMPLETED
- Phase
- PHASE2